Status:
COMPLETED
Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green Laser
Lead Sponsor:
Tampere University Hospital
Collaborating Sponsors:
Tampere University of Technology
Conditions:
Telangiectasia
Rosacea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal is to compare a novel yellow laser, based on semiconductor technology, with traditional green laser, in the treatment of cheek telangiectasias. The trial design is randomized split-face doubl...
Detailed Description
Trial design: The study is a comparative randomized split-face double-blinded study without a control group. It enables a comparison between two lasers; namely the KTP laser and the investigational PH...
Eligibility Criteria
Inclusion
- The subjects are required to be Finnish speaking adults with symmetrical facial telangiectasia, volunteering to participate in the clinical trial.
- The subjects have to have a Fitzpatrick skin phototype I-IV.
Exclusion
- pregnancy
- lactation
- hemophilic condition
- Fitzpatrick skin phototype V-VI
- drug or alcohol abuse
- subjects who are under guardianship
- subjects with significant tanning less than 6 weeks prior to the treatment day.
- unbalanced basic diseases, such as diabetes, heart disease, cancer etc.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 9 2018
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03472859
Start Date
October 1 2017
End Date
June 9 2018
Last Update
September 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Epilaser Oy
Lempäälä, Pirkanmaa, Finland, 33880